PRO ZONE
PRO ZONE, licence 80062606: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- 9265-2007 Québec Inc. Arvensis
- NPN or DIN-HM
- 80062606
- Status
- Active licence
- Licence date
- 9 July 2015
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (6E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide Source : Capsaïcine | 0.025 Pour cent | Not calculated |
| (6E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide Source : Capsicum frutescens - fruit | 0.025 Pour cent | Not calculated |
Non-medicinal ingredients
Extrait de fruits de Tasmannia lanceolata, Glycérine, Huile de graine de cannabis sativa, MSM, Undécylénate de Glycéryle, Alcool dénaturé, Copolymère d'acrylamide/Acryloyldimethyltaurate de sodium, Eau, Caprylate de Glycéryle, Isohexadecane, Poly(sorbate) 80
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12.0 Année(s) | 1.0 Gel | minimum: 1.0 Tous les jours ; maximum: 4.0 Tous les jours |
| Enfants | minimum: 2.0 Année(s) ; maximum: 12.0 Année(s) | 1.0 Gel | minimum: 1.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Soulage temporairement la douleur et les courbatures des muscles et des articulations associée(s) à une ou plusieurs des conditions suivantes: mal de dos, lumbago et la douleur arthritique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
·Garder hors de portée des enfants. ·En cas de surdosage ou d'ingestion accidentelle, appeler un Centre Antipoison immédiatement.
- Effets indésirables connus
Une sensation d'irritation et/ou de brulement peut survenir; dans ce cas, cesser l'utilisation. Une hypersensibilité peut survenir; dans ce cas, cesser l'utilisatlon. Des maux de tête, de l'érythème, de la rougeur, et une sensation de brûlement peuvent survenir; dans ce cas, cesser l'utilisation.
Source
Official Health Canada record, licence 80062606
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.